Subaru Corporation TSE:7270
Subaru : Reference for the Third Quarter of FYE 2026
Source: MarketScreener
Reference for the First Nine Months of FYE 2026 Consolidated Financial Results
February 6, 2026 Subaru Corporation
(Yen in 100 millions, Units in thousands)FYE 2025 | FYE 2026 | FYE 2025 | FYE 2026 | FYE 2026 | |||||||
Nine Months | Nine Months | Full Year | Full Year | Full Year | |||||||
[ 2024. 4-12 ] RESULTS | [ 2025. 4-12 ] RESULTS | [ '24.4 - '25.3 ] RESULTS | [ 2025.4 - 2026.3 ] FORECASTS | ['25.4-'26.3] PREVIOUS FORECASTS | |||||||
Change | % | Change | % | ||||||||
Revenue | 35,363 | 35,190 | (174) | (0.5) | 46,858 | 48,000 | 1,142 | 2.4 | 45,800 | ||
Japan | 4,738 | 5,115 | 377 | 8.0 | 6,514 | - | - | - | - | ||
Overseas | 30,626 | 30,074 | (551) | (1.8) | 40,344 | - | - | - | - | ||
Operating profit (loss) | 3,692 | 663 | (3,029) | (82.0) | 4,053 | 1,300 | (2,753) | (67.9) | 2,000 | ||
Profit margin (%) | 10.4 | 1.9 | 8.6 | 2.7 | 4.4 | ||||||
Profit (loss) before tax | 4,260 | 1,190 | (3,070) | (72.1) | 4,485 | 1,800 | (2,685) | (59.9) | 2,300 | ||
Profit margin (%) | 12.0 | 3.4 | 9.6 | 3.8 | 5.0 | ||||||
Profit (loss) for the period attributable | 3,174 | 831 | (2,343) | (73.8) | 3,381 | 1,250 | (2,131) | (63.0) | 1,600 | ||
to owners of parent Profit margin (%) | 9.0 | 2.4 | 7.2 | 2.6 | 3.5 | ||||||
Factors contributing to | Changes in business | (2,607) | U.S. additional tariff | (2,290) | |||||||
change in operating profit | environment | impacts | |||||||||
Manufacturing | Foreign exchange | ||||||||||
activities | (349) | impacts | (183) | ||||||||
Sales activities | 344 | Raw material costs | |||||||||
and market conditions | (386) | ||||||||||
Cost reduction efforts | 121 | Manufacturing and | |||||||||
sales activities, etc | 348 | ||||||||||
Other | (538) | Other | (242) | ||||||||
Exchange rates | JPY/US$ JPY/EUR | 152/US$ 163/EUR | 148/US$ 170/EUR | 152/US$ 162/EUR | 150/US$ 173/EUR | 145/US$ 155/EUR | |||||
Capital expenditures | 1,091 | 1,453 | 1,761 | 2,300 | 2,500 | ||||||
Depreciation | 714 | 742 | 968 | 1,000 | 1,000 | ||||||
R&D expenditures * | 1,052 | 1,091 | 1,600 | 1,600 | 1,600 | ||||||
Interest bearing debts | 3,975 | 4,130 | 3,995 | - | - | ||||||
Performance description | - First decrease in revenue in 4 years | - First increase in revenue in 2 years | |||||||||
- 2nd consecutive year of decrease in operating profit | |||||||||||
- First decrease in profit before tax and profit attributable to owners of parent in 4 years | - 2nd consecutive year of decrease in profits at all stages | ||||||||||
- 2nd consecutive year of decrease in consolidated unit sales | - 2nd consecutive year of decrease in consolidated unit sales | ||||||||||
Consolidated unit sales | 75 | 78 | 2 | 3.1 | 104 | 104 | (0) | (0.2) | 110 | ||
< Japan > | Passenger Cars | 66 | 67 | 1 | 1.5 | 91 | - | - | - | - | |
Minicars | 10 | 11 | 1 | 14.2 | 13 | - | - | - | - | ||
Consolidated unit sales | 632 | 598 | (34) | (5.4) | 832 | 816 | (16) | (1.9) | 810 | ||
< Overseas > | North America | 557 | 530 | (27) | (4.9) | 732 | 727 | (5) | (0.6) | 725 | |
Europe | 16 | 15 | (1) | (6.7) | 23 | 89 | (12) | (11.6) | 85 | ||
China | 2 | 2 | (0) | (18.3) | 3 | ||||||
Other | 56 | 50 | (6) | (10.0) | 75 | ||||||
Consolidated unit sales total | 707 | 676 | (32) | (4.5) | 936 | 920 | (16) | (1.8) | 920 | ||
Production units total | 725 | 657 | (68) | (9.4) | 946 | 900 | (46) | (4.9) | 900 | ||
Japan | 461 | 399 | (61) | (13.3) | 602 | - | - | - | - | ||
U.S. | 264 | 257 | (7) | (2.6) | 345 | - | - | - | - | ||
Revenue by business segment | Automobile | 34,563 | 34,192 | (371) | (1.1) | 45,690 | |||||
Aerospace | 761 | 960 | 198 | 26.0 | 1,116 | ||||||
Other | 39 | 38 | (1) | (2.8) | 51 | ||||||
Operating profit (loss) by business segment | Automobile | 3,693 | 581 | (3,112) | (84.3) | 4,204 | |||||
Aerospace | (52) | 32 | 84 | - | (196) | ||||||
Other | 46 | 44 | (2) | (3.9) | 37 | ||||||
Elimination & Corporate | 5 | 6 | 1 | 19.6 | 9 | ||||||
* "R&D expenditures" indicate R&D activity related costs incurred during the reporting period. Under IFRS, a part of these costs that meets capitalization criteria is recognized as an intangible asset and amortized over its estimated useful life; thus, the amount of "R&D expenditures" stated here does not match that of "R&D expenses" stated on the Consolidated Statement of Income.
< Forward-looking statements in this document are based on the information available at the time of the announcement and are subject to various risks and uncertainties that could cause actual results to vary materially. >